Drug standards to be used for screening and analysis testing of service member blood, urine and/or tissue samples.
Ended Awarded
- Contract number
- HT009025FG0910027
- Awardee
-
Cayman Chemical Co Inc. UEI T1ZHJRGR7TF4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $30,366
Award facts
- Contract value 100% obligated
- $30,366.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325199 All Other Basic Organic Chemical Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Ann Arbor, MI 48108, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $30,366.44 firm fixed-price blanket purchase agreement call to Cayman Chemical Co Inc., an Ann Arbor, Michigan-based biochemical manufacturer, for drug standards to be used in screening and analysis testing of service member blood, urine, and tissue samples. The award was issued on August 19, 2025, with an ultimate completion date of September 30, 2025. This BPA call carries no set-aside designation and represents work performed at the contractor's Ann Arbor facility. The contract supports the Defense Health Agency's military occupational health and readiness mission by providing certified reference materials and chemical standards essential for drug testing and forensic analysis within the military medical system.
This award is executed under Cayman Chemical Co Inc.'s existing $1.5 million single-award Blanket Purchase Agreement with the Defense Health Agency through September 2027, which authorizes the procurement of chemicals, synthetic cannabinoids, and novel psychoactive substances for military testing applications. Cayman Chemical has established itself as a specialized supplier to federal agencies since 2005, with particular expertise serving the Drug Enforcement Administration, Defense Health Agency, and Centers for Disease Control and Prevention through the provision of controlled substances, synthetic drugs, and analytical standards for law enforcement and medical screening purposes. The contractor's experience supplying reference materials for drug enforcement and forensic analysis positions it to reliably deliver the critical testing standards required to maintain screening accuracy and regulatory compliance across the military medical community.
Quick answers
Who was awarded contract HT009025FG0910027?
HT009025FG0910027 was awarded to Cayman Chemical Co Inc. by Defense Health Agency (Department of Defense) on August 19, 2025.
How much is contract HT009025FG0910027 worth?
The government has obligated $30,366 on HT009025FG0910027.
Is contract HT009025FG0910027 an order under another contract?
Yes. HT009025FG0910027 is a BPA call under W81XWH22A0007, a blanket purchase agreement.
Was contract HT009025FG0910027 competed?
The extent of competition for HT009025FG0910027 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award